A narrative review of 10 clinical trials found CBD (Epidiolex) effective in reducing seizure frequency in pediatric Dravet syndrome patients, with manageable side effects and important drug interactions.
Pediatric neurologists, families of children with Dravet syndrome, and epilepsy researchers.
10 clinical trials support CBD efficacy in pediatric Dravet syndrome
What the researchers found
Across 10 clinical trials, CBD demonstrated efficacy in reducing seizure frequency in children with Dravet syndrome. Common adverse events included somnolence, diarrhea, and decreased appetite. Interactions with clobazam were clinically significant.
Why it matters
Dravet syndrome is among the most severe childhood epilepsies with limited treatment options. CBD (Epidiolex) was the first cannabis-derived drug approved for this condition, and this review consolidates the clinical evidence.
The numbers in context
10 clinical trials reviewed. CBD reduced seizure frequency in Dravet syndrome. Common side effects: somnolence, diarrhea, decreased appetite. Clobazam interaction significant.
How the study worked
Narrative review of 10 clinical trials evaluating CBD efficacy and safety in pediatric Dravet syndrome patients.
What this study cannot tell us
Narrative review without systematic methodology or quantitative synthesis. Most trials used specific pharmaceutical-grade CBD (Epidiolex) at defined doses, which may not generalize to other CBD products. Focus on Dravet syndrome only.
How to read the evidence
Narrative review of clinical trials including RCTs. Provides useful summary but without quantitative synthesis.
When this study was published
Published 2023.
The bigger picture
The FDA approval of Epidiolex for Dravet syndrome was a landmark for cannabinoid medicine. This review confirms the evidence base supporting that decision and highlights ongoing safety considerations.
Questions still open
- Is CBD effective long-term beyond the trial durations studied? Should the clobazam-CBD interaction be leveraged therapeutically or minimized?
Common questions
Does CBD work for Dravet syndrome?
What are the side effects of CBD in Dravet syndrome?
Read the original research
The efficacy and safety of cannabidiol (CBD) in pediatric patients with Dravet Syndrome: a narrative review of clinical trials.
European journal of medical research, 29(1), 182
Citation
Aderinto, Nicholas; Olatunji, Gbolahan; Kokori, Emmanuel; Ajayi, Yusuf Ismaila; Akinmoju, Olumide; Ayedun, Abiola Samuel; Ayoola, Oluwapelumi Ikeoluwa; Aderinto, Noah Oluwaseun. (2024). The efficacy and safety of cannabidiol (CBD) in pediatric patients with Dravet Syndrome: a narrative review of clinical trials.. European journal of medical research, 29(1), 182. https://doi.org/10.1186/s40001-024-01788-6
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk